Description

The activation peptides of aspartic proteinases plays role as inhibitors of the active site. These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens. The pronapsin A gene is expressed predominantly in lung and kidney. Its translation product is predicted to be a fully functional, glycosylated aspartic proteinase precursor containing an RGD motif and an additional 18 residues at its C-terminus.

References
1. Lung Cancer. 2012 Jul;77(1):156-61. 2. Cancer Cytopathol. 2011 Oct 25;119(5):335-45.

Specification
Aliases	KAP; Kdap; NAP1; NAPA; SNAPA
Entrez GeneID	9476
Swissprot	O96009
clone	10C4B8
WB Predicted band size	45.4kDa
Host/Isotype	Mouse IgG1
Antibody Type	Primary antibody
Storage	Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species Reactivity	Human,Rat
Immunogen	Purified recombinant fragment of human NAPSA (AA: 20-158) expressed in E. Coli.
Formulation	Purified antibody in PBS with 0.05% sodium azide

Application
WB	1/500 - 1/2000
IHC	1/200 - 1/1000
ELISA	1/10000